CONSUMER NEWS    RECALLS    COMPLAINT FORM    SCAM ALERTS  


Complain about a product or service

Small Claims Guide | Class Actions | Lemon Law | FAQ | Resources | Newsletters | Spanish
Automotive    Education    Electronics    Family    Finance    Health    Homeowners    Shopping    Travel   
NEWS   Latest |  Archives |  Auto |  Cells, etc. |  Computers |  Financial |  Health |  Homeowners |  Parents |  Privacy |  Scams |  Seniors |  Travel

COX-2 Painkillers Restricted in Europe



February 23, 2005
While the U.S. Food and Drug Administration (FDA) considers an expert panel's recommendation that Vioxx be allowed to return to the market, the European Medicines Agency (EMA) has restricted use in the European Union of COX-2 painkillers because of the increased risk of adverse cardiovascular events.

COX-2 Drugs
Bextra
Celebrex
Vioxx
---
News
Celebrex May Disrupt Heart Rhythm
FDA Rejects Arcoxia As Arthritis Drug
FDA Panel Rejects Vioxx Replacement
FDA Panel Members Indebted to Drug Companies
COX-2 Painkillers Restricted in Europe
Researchers Ignored Early COX-2 Warnings
FDA to Improve Drug Safety Monitoring
FDA Convenes COX-2 Meeting
FDA Blasts Ads For Celebrex, Bextra
Feds Issue Caution On All COX-2 Drugs
British Heart Patients Told to Stop Taking Cox-2 Drugs
Researchers Warn of Dangers

A federal advisory panel earlier this month gave Merck a yellow light to bring painkiller Vioxx back onto the market, provided it carries a black box warning that it raises the risk of heart attack and stroke.

The EMA approved revisions to the prescribing information for COX-2 painkillers to warn healthcare professionals of the increased risk of adverse cardiovascular events, including myocardial infarction and stroke, associated with their use.

The restrictions apply to medications available in the U.S. such as Celebrex and Bextra, made by Pfizer, as well as COX-2 inhibitors available only in the EU. Use of COX-2 inhibitors is now contraindicated in patients with ischemic heart disease or a history of stroke.

According to the EMA, the available data suggest an association between COX-2 inhibitor exposure and cardiovascular risk. Use of these medications should therefore be restricted to the lowest effective dose for the shortest possible duration of treatment.

The EMA advises caution when prescribing COX-2 inhibitors for patients with risk factors for heart disease, including hypertension, hyperlipidemia, diabetes, peripheral arterial disease, and current smoking.

COX-2 inhibitors are indicated in the EU for the treatment of rheumatoid arthritis and other painful conditions.



Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.


Consumer News

September 6 2008

Recent Recalls & Safety Alerts



FREE CONSUMER NEWSLETTERS

The Daily Consumer
Afternoons M-F

Sign up now!


Consumer News & Alerts
Every Sunday

Sign up now!


Knowledge is free.
Knowledge is power.



Back to the top |

Advertisement


Home | Complaint Form | News | Recalls | FAQ |
Consumer Resources | Small Claims Guide | Lemon Law | Newsletter | Contact Us
Advertise With Us | Testimonials | Newsroom | RSS Feeds |


Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2003-2008 ConsumerAffairs.com Inc.  All Rights Reserved.    The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.